Anthem Biosciences Ltd.

•

anthembio.comBSE: 544449NSE: ANTHEM

Market Cap₹ 53,067 Cr.

Current Price

High / Low₹ 978 / 579

Stock P/E92.1

Book Value₹ 56

Price to Book12.25

Dividend Yield0.21 %

ROCE29.6 %

ROE22.0 %

Face Value₹ 2

Add ratio to table

ABOUT

KEY POINTS

Revenue Breakup Mar 2026 • Contract Manufacturing Development & Discovery Services (CRDMO ): 83.4% • Speciality Ingredients: 16.6%

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence

50%

View full sector analysis →

PROS

Company is almost debt free
Company has a healthy return on capital (ROCE) of 27.5%
Company has a good return on equity (ROE) track record: 3 Years ROE 21.0%
Company has consistently been profitable over the last 5 years
Company comfortably covers its interest (117.8x coverage)
Institutional investors have been accumulating - FII+DII up 11.0pp

CONS

Promoter holding has decreased over last 2 years: -12.6pp
Receivables are growing faster than sales - a possible quality concern
Stock is trading at 12.3x its book value
Operating margins have contracted to 38.2% from 48.1%
Expensive relative to growth - PEG of 6.0

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareHealthcarePharmaceuticals & Drugs

Part ofNIFTYLARGEMIDCAP250 NIFTYMIDCAP150 NIFTY MIDCAP 150 NIFTY TOTAL MKT NIFTY 500

S.No.	Name
1.	SUNPHARMA	1864.00	36.98	447236.04	0.86	2901.23	26.53	15299.88	10.98	19.11	28.81
2.	DIVISLAB	9405.00	85.36	249673.20	0.32	902.00	65.50	3080.00	27.80	21.51	40.75
3.	TORNTPHARM	4928.40	85.95	187460.49	0.77	566.00	3.28	4921.00	57.32	19.27	33.81
4.	ZYDUSLIFE	1118.00	24.71	111520.93	0.09	990.20	-34.90	8017.00	23.97	21.39	24.54
5.	CIPLA	1380.00	33.08	111484.47	0.94	785.55	-39.18	7119.28	4.13	16.00	16.73
6.	LAURUSLABS	1936.00	95.67	104604.45	0.10	362.07	123.94	2026.31	29.10	18.20	31.50
7.	AUROPHARMA	1669.00	25.87	96030.57	0.24	1032.03	25.22	9150.35	17.44	12.76	20.54
8.	DRREDDY	1140.80	29.55	95220.28	0.70	435.60	-69.10	8099.80	-5.21	13.75	10.63
9.	LUPIN	2075.00	17.16	94882.67	0.87	1416.98	16.01	8276.89	34.28	28.86	29.59
10.	MANKIND	2246.00	45.42	92769.93	0.04	574.09	29.12	4030.59	12.89	13.24	26.30
11.	GLENMARK	2417.00	37.94	68213.70	0.10	482.83	927.88	4018.48	31.35	20.35	20.03
12.	ANTHEM	941.70	92.14	53067.44	0.21	119.94	-11.67	418.22	-22.58	29.62	36.00

Detailed Comparison with:

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	339	525	498	483	540	550	423	611	418
	218	330	338	288	349	332	266	344	299
Operating Profit	121	195	160	195	191	218	157	267	120
OPM %	35.71%	37.19%	32.04%	40.40%	35.45%	39.62%	37.15%	43.74%	28.62%
	19	28	24	14	23	48	8	52	25
Interest	4	4	3	1	2	3	0	2	1
Depreciation	19	20	20	30	26	34	35	40	30
Profit before Tax	118	200	161	178	186	230	130	278	145
Tax %	30.17%	18.85%	22.80%	53.66%	27.09%	24.46%	28.86%	31.72%	17.04%
Net Profit	0	0	0	0	136	173	93	190	120
	1.47	2.90	2.22	1.48	2.43	3.09	1.65	3.38	2.13

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2015	Mar 2016	Mar 2017	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
	248	308	356	633	1,103	1,231	1,057	1,419	1,845	2,124	2,002
	178	215	248	451	696	664	634	914	1,174	1,290	1,240
Operating Profit	70	94	108	182	408	567	423	505	671	834	762
OPM %	28.32%	30.37%	30.40%	28.75%	36.96%	46.06%	40.01%	35.59%	36.38%	39.26%	38.06%
	3	5	7	21	37	49	147	64	86	131	133
Interest	6	5	5	20	17	12	9	10	11	7	6
Depreciation	10	21	22	62	62	58	64	82	89	134	138
Profit before Tax	58	73	88	121	366	546	497	477	657	824	783
Tax %	32.47%	31.13%	25.04%	23.18%	25.79%	25.74%	22.54%	23.05%	31.30%	28.20%	26.40%
Net Profit	39	50	66	93	271	406	385	367	451	592	576
EPS	46.07	37.18	78.86	108.00	323.41	7.11	6.75	6.57	8.07	10.54	—
Dividend Payout %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	18.98%	—

COMPOUNDED SALES GROWTH

10 Years:: 32%
5 Years:: 14%
3 Years:: 26%

COMPOUNDED PROFIT GROWTH

10 Years:: 43%
5 Years:: 17%
3 Years:: 15%

STOCK PRICE CAGR

10 Years:: —
5 Years:: —
3 Years:: —
1 Year:: 15%

RETURN ON EQUITY

10 Years:: 33%
5 Years:: 25%
3 Years:: 21%
Last Year:: 22%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2015	Mar 2016	Mar 2017	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	8	8	8	8	8	9	114	112	112	112
	89	138	213	413	693	1,346	1,627	1,813	2,264	2,897
	79	120	191	136	120	62	133	249	107	49
Trade Payables	24	26	33	58	77	65	72	101	110	75
	35	64	65	159	192	244	159	202	356	473
Total Liabilities	235	355	510	776	1,091	1,726	2,105	2,477	2,949	3,606
	91	86	258	306	361	329	449	483	705	783
Capital Work in Progress	22	74	43	50	19	154	164	345	297	264
	2	8	27	99	209	273	499	472	433	1,007
	37	47	58	125	35	58	129	211	340	125
	0	0	0	0	0	0	0	490	450	591
Cash & Bank	2	4	11	22	41	349	343	184	172	275
	81	136	113	174	426	563	520	292	550	561
Total Assets	235	355	510	776	1,091	1,726	2,105	2,477	2,949	3,606

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	211	349	456	421	140	271	844
Cash from Investing	-109	-196	-205	-376	-221	-147	-702
Cash from Financing	-48	-63	181	64	-77	-136	-40
	9	18	308	-6	-158	-12	103

Ratios

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2015	Mar 2016	Mar 2017	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026

Shareholding Pattern

Numbers in percentages

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Jul 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	84.00	82.96	76.85	76.84	74.69	74.69	74.69	74.68	71.42
	0.00	0.00	0.00	0.00	1.50	1.66	1.37	1.28	2.57
	0.00	0.00	0.00	0.00	3.59	7.21	7.60	11.55	13.48
Government	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	16.00	17.04	23.15	23.16	20.22	16.42	16.35	12.49	12.53

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-09-08

Updates

2026-09-08 - Anthem Biosciences Limited has informed the Exchange regarding 'Settlement of Upside Sharing Arrangement '.

2026-07-27

Analysts/Institutional Investor Meet/Con. Call Updates

2026-07-27 - Anthem Biosciences Limited has informed the Exchange about Transcript

2026-07-24

Shareholders meeting

2026-07-24 - Anthem Biosciences Limited has submitted the Exchange the voting results and a copy Srutinizers report of the 20th Annual General Meeting held on July 22, 2026.

2026-07-22

Shareholders meeting

2026-07-22 - Anthem Biosciences Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on July 22, 2026

2026-07-22

Analysts/Institutional Investor Meet/Con. Call Updates

2026-07-22 - Anthem Biosciences Limited has informed the Exchange about Link of Recording

2026-07-22

Copy of Newspaper Publication

2026-07-22 - Anthem Biosciences Limited has informed the Exchange about Copy of Newspaper Publication

2026-07-21

Press Release (Revised)

2026-07-21 - Anthem Biosciences Limited has informed the Exchange regarding a revised press release dated July 21, 2026, titled "Press Release on Unaudited Financial Results for the Quarter ended June 30, 2026".

2026-07-21

Investor Presentation

2026-07-21 - Anthem Biosciences Limited has informed the Exchange about Investor Presentation

2026-07-21

Press Release

2026-07-21 - Anthem Biosciences Limited has informed the Exchange regarding a press release dated July 21, 2026, titled "Press Release on the Unaudited Financial Results for the quarter ended June 30, 2026".

News

Recent coverage and analyst commentary for ANTHEM

Loading news…

🤖

AI Stock Analyst

Anthem Biosciences Ltd.

🔒

Sign in to Chat with AI

✨ Sign In to Chat

Free 5nance Account